Klaus-Henning Kahl

994 total citations
23 papers, 182 citations indexed

About

Klaus-Henning Kahl is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Epidemiology. According to data from OpenAlex, Klaus-Henning Kahl has authored 23 papers receiving a total of 182 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 11 papers in Genetics and 8 papers in Epidemiology. Recurrent topics in Klaus-Henning Kahl's work include Brain Metastases and Treatment (12 papers), Glioma Diagnosis and Treatment (11 papers) and Meningioma and schwannoma management (7 papers). Klaus-Henning Kahl is often cited by papers focused on Brain Metastases and Treatment (12 papers), Glioma Diagnosis and Treatment (11 papers) and Meningioma and schwannoma management (7 papers). Klaus-Henning Kahl collaborates with scholars based in Germany, United States and Switzerland. Klaus-Henning Kahl's co-authors include Stefanie Brehmer, Christopher P. Cifarelli, John A. Vargo, Gustavo R. Sarria, Frank A. Giordano, Oliver Blanck, Matthias Gückenberger, Ehab Shiban, Fabian Lohaus and Shankar Siva and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology and Radiotherapy and Oncology.

In The Last Decade

Klaus-Henning Kahl

20 papers receiving 178 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klaus-Henning Kahl Germany 7 157 83 53 47 44 23 182
Mélanie Dore France 9 140 0.9× 71 0.9× 47 0.9× 47 1.0× 23 0.5× 17 208
Chiara Reverberi Italy 10 178 1.1× 43 0.5× 93 1.8× 19 0.4× 39 0.9× 25 257
Evgeny Sadikov Canada 8 93 0.6× 42 0.5× 95 1.8× 36 0.8× 31 0.7× 16 180
Annie Ébacher Canada 4 174 1.1× 57 0.7× 23 0.4× 43 0.9× 30 0.7× 7 184
Michael A. Vogelbaum United States 7 283 1.8× 192 2.3× 152 2.9× 89 1.9× 31 0.7× 10 307
Juliana Matiello Brazil 6 159 1.0× 248 3.0× 49 0.9× 90 1.9× 16 0.4× 11 300
V. Sinaika Austria 4 154 1.0× 248 3.0× 35 0.7× 85 1.8× 15 0.3× 7 278
Karen Allen United States 7 205 1.3× 178 2.1× 47 0.9× 64 1.4× 26 0.6× 15 268
Fabio Arcidiacono Italy 7 114 0.7× 16 0.2× 26 0.5× 23 0.5× 43 1.0× 26 199
Sophia Scharl Germany 9 62 0.4× 45 0.5× 25 0.5× 50 1.1× 53 1.2× 23 203

Countries citing papers authored by Klaus-Henning Kahl

Since Specialization
Citations

This map shows the geographic impact of Klaus-Henning Kahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus-Henning Kahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus-Henning Kahl more than expected).

Fields of papers citing papers by Klaus-Henning Kahl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus-Henning Kahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus-Henning Kahl. The network helps show where Klaus-Henning Kahl may publish in the future.

Co-authorship network of co-authors of Klaus-Henning Kahl

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus-Henning Kahl. A scholar is included among the top collaborators of Klaus-Henning Kahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus-Henning Kahl. Klaus-Henning Kahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
6.
Layer, Julian Philipp, Ehab Shiban, Stefanie Brehmer, et al.. (2024). Multicentric Assessment of Safety and Efficacy of Combinatorial Adjuvant Brain Metastasis Treatment by Intraoperative Radiation Therapy and Immunotherapy. International Journal of Radiation Oncology*Biology*Physics. 118(5). 1552–1562. 8 indexed citations
8.
Kahl, Klaus-Henning, Ehab Shiban, Christoph J. Maurer, et al.. (2022). Focal cavity radiotherapy after neurosurgical resection of brain metastases: sparing neurotoxicity without compromising locoregional control. Strahlentherapie und Onkologie. 198(12). 1105–1111. 6 indexed citations
9.
Kahl, Klaus-Henning, et al.. (2022). Intraoperative radiotherapy during awake craniotomies: preliminary results of a single-center case series. Neurosurgical Review. 45(6). 3657–3663. 5 indexed citations
10.
Shiban, Ehab, et al.. (2022). Resection of supratentorial brain metastases with intraoperative radiotherapy. Is it safe? Analysis and experiences of a single center cohort. Frontiers in Surgery. 9. 1071804–1071804. 7 indexed citations
11.
Kahl, Klaus-Henning, Michael Höck, Sabine Schill, et al.. (2021). Intraoperative radiotherapy with low-energy x-rays after neurosurgical resection of brain metastases—an Augsburg University Medical Center experience. Strahlentherapie und Onkologie. 197(12). 1124–1130. 20 indexed citations
12.
Kroeze, Stephanie, Corinna Fritz, David Kaul, et al.. (2021). Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the ‘TOaSTT’ database. Radiation Oncology. 16(1). 4–4. 22 indexed citations
13.
Mayr, N. Patrick, Rainer Claus, Matthias Anthuber, et al.. (2020). Neoadjuvant and Definitive Radiochemotherapeutic Approaches in Esophageal Cancer: A Retrospective Evaluation of 122 Cases in Daily Clinical Routine. Oncology Research and Treatment. 43(7-8). 372–379. 3 indexed citations
14.
Kroeze, Stephanie, Corinna Fritz, Shankar Siva, et al.. (2020). Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma. British Journal of Urology. 127(6). 703–711. 21 indexed citations
15.
Kroeze, Stephanie, Corinna Fritz, David Kaul, et al.. (2019). Stereotactic radiotherapy concurrent to immune or targeted therapy for oligometastatic NSCLC: Clinical scenarios affecting survival. Annals of Oncology. 30. ii63–ii63. 3 indexed citations
16.
Cifarelli, Christopher P., Stefanie Brehmer, John A. Vargo, et al.. (2019). Intraoperative radiotherapy (IORT) for surgically resected brain metastases: outcome analysis of an international cooperative study. Journal of Neuro-Oncology. 145(2). 391–397. 40 indexed citations
17.
Duma, Marciana Nona, Oliver Blanck, Guido Hildebrandt, et al.. (2017). Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma—a multicenter analysis of the German working group “Stereotactic Radiotherapy”. Journal of Thoracic Disease. 9(11). 4512–4522. 31 indexed citations
18.
Sterzing, Florian, Jan Streblow, K. Scherer, et al.. (2014). SBRT for Lung Metastases: A Pooled Analysis of 651 Patients and 868 Lesions of the German Working Group Stereotactic Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 90(1). S31–S31. 1 indexed citations
19.
Kahl, Klaus-Henning, et al.. (1977). Otitis externa maligna. European Archives of Oto-Rhino-Laryngology. 216(2). 516–517. 2 indexed citations
20.
Kahl, Klaus-Henning, et al.. (1972). [Exophthalmogenic effect produced by endogenous and exogenous thyrotropic hormone in animal experiments. Studies with mercaptoimidazole, perchlorate and sera from hypothyroid patients without exophthalmos].. PubMed. 102(19). 667–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026